| Primary |
| Bipolar Disorder |
37.2% |
| Bipolar I Disorder |
15.0% |
| Mania |
12.1% |
| Product Used For Unknown Indication |
10.6% |
| Anxiety |
3.4% |
| Depression |
2.4% |
| Affective Disorder |
1.9% |
| Depressive Symptom |
1.9% |
| Mood Swings |
1.9% |
| Depressive Delusion |
1.4% |
| General Physical Health Deterioration |
1.4% |
| Insomnia |
1.4% |
| Mood Altered |
1.4% |
| Psychotic Disorder |
1.4% |
| Sleep Disorder |
1.4% |
| Delusion |
1.0% |
| Diabetes Mellitus |
1.0% |
| Hyperlipidaemia |
1.0% |
| Major Depression |
1.0% |
| Schizoaffective Disorder |
1.0% |
|
| Completed Suicide |
10.3% |
| Off Label Use |
6.9% |
| Rash |
6.9% |
| Swollen Tongue |
6.9% |
| Vertigo |
6.9% |
| Drug Ineffective |
5.2% |
| Sedation |
5.2% |
| Suicidal Ideation |
5.2% |
| Syncope |
5.2% |
| Vomiting |
5.2% |
| Weight Increased |
5.2% |
| Drug Interaction |
3.4% |
| Hospitalisation |
3.4% |
| Hypersensitivity |
3.4% |
| Mania |
3.4% |
| Paraesthesia |
3.4% |
| Prescribed Overdose |
3.4% |
| Pruritus |
3.4% |
| Pulmonary Embolism |
3.4% |
| Rash Generalised |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
30.8% |
| Bipolar Disorder |
22.6% |
| Mania |
12.0% |
| Bipolar I Disorder |
6.0% |
| Depressive Symptom |
4.5% |
| Anxiety |
3.0% |
| Mood Swings |
3.0% |
| General Physical Health Deterioration |
2.3% |
| Schizophrenia |
2.3% |
| Affective Disorder |
1.5% |
| Hormone Replacement Therapy |
1.5% |
| Hypothyroidism |
1.5% |
| Insomnia |
1.5% |
| Psychotic Disorder |
1.5% |
| Schizoaffective Disorder |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Aggression |
0.8% |
| Autoimmune Thyroiditis |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Hypertriglyceridaemia |
0.8% |
|
| Sedation |
12.1% |
| Hepatitis Toxic |
9.1% |
| Self Injurious Behaviour |
9.1% |
| Visual Acuity Reduced |
9.1% |
| Paraesthesia |
6.1% |
| Pruritus |
6.1% |
| Rash |
6.1% |
| Urinary Incontinence |
6.1% |
| Alcoholism |
3.0% |
| Drug Ineffective |
3.0% |
| Hospitalisation |
3.0% |
| Hypersomnia |
3.0% |
| Impaired Work Ability |
3.0% |
| Insomnia |
3.0% |
| Joint Swelling |
3.0% |
| Local Swelling |
3.0% |
| Mania |
3.0% |
| Nightmare |
3.0% |
| Off Label Use |
3.0% |
| Prescribed Overdose |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.6% |
| Schizophrenia, Paranoid Type |
26.3% |
| Decompensation Cardiac |
10.5% |
| Hypertension |
10.5% |
| Insomnia |
10.5% |
| Nervousness |
10.5% |
|
| Pericarditis |
28.6% |
| Pruritus |
28.6% |
| Psychotic Disorder |
14.3% |
| Schizoaffective Disorder |
14.3% |
| Shock Haemorrhagic |
14.3% |
|
| Interacting |
| Mania |
30.8% |
| Bipolar I Disorder |
17.9% |
| Sleep Disorder |
12.8% |
| Product Used For Unknown Indication |
10.3% |
| Bipolar Disorder |
7.7% |
| Chronic Obstructive Pulmonary Disease |
7.7% |
| Respiratory Tract Infection Bacterial |
7.7% |
| Hyperlipidaemia |
2.6% |
| Tension |
2.6% |
|
| Tension |
47.1% |
| Affect Lability |
23.5% |
| Respiratory Tract Infection Bacterial |
17.6% |
| Myoglobin Blood Increased |
5.9% |
| Prescribed Overdose |
5.9% |
|
